1
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D. C. 20549
FORM 8-K
CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE
SECURITIES EXCHANGE ACT OF 1934
Date of Report (Date of earliest event reported): July 20, 2000
MOLECULAR DEVICES CORPORATION
(Exact name of registrant as specified in its charter)
DELAWARE
(State or other jurisdiction of incorporation)
0-27316 94-2914362
(Commission File No.) (IRS Employer Identification No.)
1311 ORLEANS DRIVE
SUNNYVALE, CALIFORNIA 94089
(Address of principal executive offices and zip code)
Registrant's telephone number, including area code: (408) 747-1700
------------------------------
2
ITEM 7. EXHIBITS.
99.1 Press Release, dated as of July 20, 2000 entitled "Molecular
Devices Reports Record Revenues and Earnings for Second
Quarter and First Half of 2000."
1.
3
SIGNATURE
Pursuant to the requirements of the Securities Exchange Act of 1934, the
registrant has duly caused this report to be signed on its behalf by the
undersigned, thereunto duly authorized.
MOLECULAR DEVICES CORPORATION
Dated: July 20, 2000 By: /s/ TIMOTHY A. HARKNESS
--------------------------------
TIMOTHY A. HARKNESS
VICE PRESIDENT OF FINANCE AND
CHIEF FINANCIAL OFFICER
2.
4
INDEX TO EXHIBITS
99.1 Press Release, dated as of July 20, 2000 entitled "Molecular
Devices Reports Record Revenues and Earnings for Second
Quarter and First Half of 2000."
3.